首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 张翔
2023
CA
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma
Cancer Biol Med, 10.20892/j.issn.2095-3941.2023.0394
FA
Excess body weight: Novel insights into its roles in obesity comorbidities
SEMIN CANCER BIOL, 10.1016/j.semcancer.2023.03.008
2022
FA
Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients
Oncogene, 10.1038/s41388-022-02395-7
点击查看热心肠日报解读
CA
The Role of Gut-Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
Biomedicines, 10.3390/biomedicines10030524
2021
CA
Diet and gut microbiome in fatty liver and its associated liver cancer
J GASTROEN HEPATOL, 10.1111/jgh.15713
2020
FA
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
Gut, 10.1136/gutjnl-2019-319664
点击查看热心肠日报解读
2019
FA
New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer
Cancer Lett, 10.1016/j.canlet.2019.114425
FA
Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells
J Path, 10.1002/path.5275
FA
Macrophage p38α promotes nutritional steatohepatitis through M1 polarization
J HEPATOL, 10.1016/j.jhep.2019.03.014
2018
FA
CA
NAFLD Related-HCC: The Relationship with Metabolic Disorders
ADV EXP MED BIOL, 10.1007/978-981-10-8684-7_5
2017
FA
Pro-Inflammatory CXCR3 Impairs Mitochondrial Function in Experimental Non-Alcoholic Steatohepatitis
THERANOSTICS, 10.7150/thno.21400